Cannabis stocks, as measured by the Global Cannabis Stock Index, bounced back sharply from Q4 losses of 44.2%, rallying 44.2% in January to 92.33: The index, which had 43 qualifying...

Cannabis stocks, as measured by the Global Cannabis Stock Index, extended the declines from mid-October, declining 10.0% to 80.32 in November: The index, which has 61 qualifying members after the...

Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF), the world’s first and still only cannabis ETF, has adjusted its portfolio this month as its benchmark, the North...

22nd Century Launches Major New Initiative to Produce Medically-Important Marijuana Cannabinoids 22nd Century is only U.S. firm able to operate freely in the cannabinoid biosynthetic pathway; Company intends to...